Geisinger Commonwealth School of Medicine's Eshiemomoh Osilama accepted to HIV Vaccine Trials Network's scholar program
The HIV Vaccine Trials Network (HVTN) has notified Eshiemomoh Osilama, a member of Geisinger Commonwealth School of Medicine's MD Class of 2024, that he has been accepted to its highly competitive Research and Mentorship Program (RAMP), a scholar program for African American/Black and Latinx medical students.
To view these students click here: https://gcsom.meritpages.com/achievements/Geisinger-Commonwealth-School-of-Medicine-s-Eshiemomoh-Osilama-accepted-to-HIV-Vaccine-Trials-Network-s-scholar-program/132172
Recent News
- Geisinger Commonwealth School of Medicine celebrates successful Match Day
- Geisinger Commonwealth School of Medicine student publishes paper in Journal of Studies on Alcohol and Drugs
- Edward Liu, a member of Geisinger Commonwealth School of Medicine's MD Class of 2025, publishes paper in journal, Medical Cannabis and Cannabinoids
- Geisinger Commonwealth School of Medicine student, Edward Liu, publishes paper in Frontiers in Pharmacology journal
- Geisinger Commonwealth School of Medicine student, Rhudjerry Arnet, published in journal, Pharmaceuticals
- Two Geisinger Commonwealth medical students publish paper in journal Pharmacopsychiatry.
- Edward Liu, a Geisinger Commonwealth School of Medicine student, presents research at conferences
- Geisinger Commonwealth School of Medicine student Cate Falkenstein receives commendation from the American Balint Society
- Geisinger Commonwealth School of Medicine students publish paper on methadone distribution trends
- Pharmacology Research & Perspectives journal publishes paper authored by Geisinger Commonwealth School of Medicine students, alumni
...more
